Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

15 Jun, 2018, 07:30 BST European Hematology Association: Iron: a double-edged Sword in Inflammation

Iron is a vital element required for several biologic functions, first of all oxygen delivery to tissues, which occurs through the...


15 Jun, 2018, 07:30 BST European Hematology Association: Update on bb2121, a Promising Therapy for Patients with Heavily Pre-treated Relapsed/Refractory Multiple Myeloma

The anti-BCMA CAR T cell therapy bb2121 has demonstrated substantial activity in heavily pre-treated patients with multiple myeloma (MM). Updated...


15 Jun, 2018, 07:30 BST European Hematology Association: Is RELEVANCE Relevant? Results of the Phase III Study of R2 vs R-chemo in First-line Follicular Lymphoma

Chemoimmunotherapy (R-chemo) induction followed by rituximab maintenance is the standard of care in previously untreated, symptomatic follicular...


15 Jun, 2018, 07:30 BST European Hematology Association: First-in-Human CLL1-CD33 Compound CAR T Cells as a Two-Pronged Approach for the Treatment of Refractory Acute Myeloid Leukemia

Purpose: To firstly study the anti-leukemic activity of the CLL1-CD33 compound CAR in vitro and in vivo and consequently offer opportunities to...


15 Jun, 2018, 07:30 BST European Hematology Association: AHL2011: Outstanding Disease Control With a Minimized BEACOPP Exposure and Toxicity in Patients With Advanced Hodgkin Lymphoma

Six cycles of BEACOPP provide a better long-term disease control than ABVD in advanced Hodgkin lymphoma but is associated to more frequent...


14 Jun, 2018, 14:25 BST European Hematologists to Discuss Breakthroughs in Blood Disorders in Stockholm, Sweden on June 14-17, 2018

More than 11,000 participants from around the world are expected at the upcoming 23rd Congress of the European Hematology Association (EHA) at...


14 Jun, 2018, 08:48 BST EMOSIS Announces an Exclusive Distribution Agreement with 5-Diagnostics and the Start of Commercialization

Emosis starts selling HIT Confirm®, Emosis' first test, through 5-Diagnostics' international network Emosis, a medical device company...


13 Jun, 2018, 12:07 BST Nordic Nanovector Announces Archer-1 Trial of Betalutin® plus Rituximab in 2L Follicular Lymphoma Approved to Start in Norway

Nordic Nanovector ASA (OSE: NANO) has received approval from the Regional Committees for Medical and Health Research Ethics (REK) in Norway with...


12 Jun, 2018, 12:52 BST Galmed's 600 mg Aramchol™ Achieved a Regulatory Approvable Endpoint Showing NASH Resolution Without Worsening of Fibrosis, in NASH Patients, in the Global Phase 2b ARREST 52-Week Study

- Statistically significant reduction in liver fat was demonstrated by Magnetic Resonance Spectroscopy (MRS) in patients completing 52...


12 Jun, 2018, 12:25 BST Grünenthal Initiates Pivotal Phase III Trials in Complex Regional Pain Syndrome

Grünenthal announced today that first patients have been enrolled in two trials of the company's pivotal phase III program investigating...


12 Jun, 2018, 09:00 BST icotec AG Received FDA Clearance to Market BlackArmor® Carbon/PEEK Interbody Cages

The BlackArmor® Carbon/PEEK cervical and lumbar interbody cages are composed of icotec's innovative material, which is radiolucent and rapidly...


11 Jun, 2018, 15:30 BST Pharmaleads Presents New Data Showing DENKIs, a New Class of Painkillers, to be Devoid of Abuse Potential and Opiate Side-Effects

Clinical and preclinical data demonstrating efficacy, safety and tolerability presented at the Annual International Conference on Opioids in...


11 Jun, 2018, 13:30 BST PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin® With Pint Pharma International

PharmaMar (MCE: PHM) has announced today the signing of a commercialization and distribution license agreement with Pint Pharma International,...


11 Jun, 2018, 13:13 BST TrialScope Appoints Francine Lane as Vice President of Global Transparency

Newly created position designed to help sponsors meet the growing pressure to improve global clinical trial disclosure TrialScope, the...


11 Jun, 2018, 12:00 BST Replimune Appoints Dr. Hyam I. Levitsky to Board of Directors

Replimune Group Inc., a biotechnology company developing next generation oncolytic immunotherapies, announced today it has appointed Hyam I....


11 Jun, 2018, 07:00 BST ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System

Recruitment Begins in 7 European Countries BTG plc (LSE: BTG), the global healthcare company, today announces the start of ELEVATE: A randomizEd...


11 Jun, 2018, 06:26 BST Nordic Nanovector to Present Preclinical Data Demonstrating Betalutin® Reverses Resistance to Anti-CD20 Treatment in NHL Cells

Nordic Nanovector ASA (OSE: NANO) announces that a poster reporting the ability of Betalutin® (177Lu-lilotomab satetraxetan) to reverse resistance...


07 Jun, 2018, 22:00 BST Microbiotix presents new data at the ASM Microbe 2018 Conference

Seven presentations with data from multiple pipeline candidates including data from Microbiotix's innovative non-antibiotic programs targeting...


07 Jun, 2018, 07:00 BST 4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Patients With Solid Tumours

4D pharma plc (AIM: DDDD) today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) to...


07 Jun, 2018, 06:00 BST New UCB Data Presented at the Annual European Congress of Rheumatology (EULAR 2018) Serves Key Patient Populations Including Ankylosing Spondylitis, Psoriatic Arthritis, and Women with Chronic Inflammatory Diseases

- Late-breaking oral presentation on bimekizumab shows significant potential for treating ankylosing spondylitis (AS) - Oral...


06 Jun, 2018, 13:00 BST Iterum Therapeutics to Present Data on Prevalence of Resistant Infections and In Vitro Activity of its Novel Antibiotic Sulopenem

In U.S. patients, quinolone non-susceptibility seen in over 20 per cent of isolates from the urinary tract, driven primarily by resistance in E....


06 Jun, 2018, 12:00 BST Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program

–– Novel, Oral Fumarate Therapy Intended to Provide a Differentiated Gastrointestinal Tolerability Profile –– –– New Drug Application Anticipated...


05 Jun, 2018, 13:30 BST PharmaMar Presents in Oral Session at ASCO: The ADMYRE Study's Adjusted Overall Survival With Plitidepsin

Abstract #8018 - The modelled data on overall survival of the statistical evaluation of the impact of crossover on the ADMYRE...


05 Jun, 2018, 13:00 BST IMI-PainCare: Public-private Partnership Tackles Major Challenges in the Care of Pain Patients

To improve the care of patients with acute or chronic pain, a consortium from academia, small and medium-sized enterprises (SMEs), pain societies,...


05 Jun, 2018, 13:00 BST Thermo Fisher Scientific supports the European STATIN trial to evaluate pravastatin in the potential prevention of preeclampsia

Research results suggest a preventive role of statins in the late-onset form of preeclampsia The STATIN trial (RandomiSed conTrolled trial...